Log in

CVE:CDCCadillac Ventures Stock Price, Forecast & News

C$0.04
0.00 (0.00 %)
(As of 06/26/2020)
Add
Compare
Today's Range
C$0.04
Now: C$0.04
C$0.04
50-Day Range
C$0.02
MA: C$0.03
C$0.04
52-Week Range
C$0.01
Now: C$0.04
C$0.04
Volume1,000 shs
Average Volume76,026 shs
Market CapitalizationC$3.18 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cadillac Ventures Inc. engages in the acquisition, exploration, and development of mineral properties in Canada. It holds interests in the Burnt Hill property, a tungsten tin project located outside of Fredericton, New Brunswick; and the Thierry project covering approximately 11,000 acres located in northwestern Ontario, as well as the Kirkland Lake/Grenfell gold property located to the west of the town of Kirkland Lake, Ontario. The company was incorporated in 1995 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.23 out of 5 stars


Industry, Sector and Symbol

Industry Industrial Metals & Minerals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-416-2037722

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC$0.19 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$3.18 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CDC News and Ratings via Email

Sign-up to receive the latest news and ratings for CDC and its competitors with MarketBeat's FREE daily newsletter.

Cadillac Ventures (CVE:CDC) Frequently Asked Questions

How has Cadillac Ventures' stock been impacted by COVID-19 (Coronavirus)?

Cadillac Ventures' stock was trading at C$0.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CDC shares have increased by 16.7% and is now trading at C$0.04. View which stocks have been most impacted by Coronavirus.

Has Cadillac Ventures been receiving favorable news coverage?

News stories about CDC stock have trended negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cadillac Ventures earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View the latest news about Cadillac Ventures.

Who are some of Cadillac Ventures' key competitors?

Who are Cadillac Ventures' key executives?

Cadillac Ventures' management team includes the following people:
  • Mr. Norman E. Brewster P.Geo, Pres, CEO & Director (Age 72)
  • Mr. Kyle Appleby, Chief Financial Officer
  • Mr. George Arthur Duguay C.P.A., C.G.A., F.C.I.S., Corp. Sec. (Age 66)

What is Cadillac Ventures' stock symbol?

Cadillac Ventures trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CDC."

How do I buy shares of Cadillac Ventures?

Shares of CDC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Cadillac Ventures' stock price today?

One share of CDC stock can currently be purchased for approximately C$0.04.

How big of a company is Cadillac Ventures?

Cadillac Ventures has a market capitalization of C$3.18 million.

What is Cadillac Ventures' official website?

The official website for Cadillac Ventures is www.cadillacventures.com.

How can I contact Cadillac Ventures?

Cadillac Ventures' mailing address is 82 Richmond St E Suite 201, TORONTO, ON M5C 1P1, Canada. The company can be reached via phone at +1-416-2037722.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.